Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Nature Communications|August 21, 2021
Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4Johanna Diener, Arianna Baggiolini, Mattias Pernebrink, et al.Plos One|October 2, 2015
Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?Joanna Mangana, Phil F Cheng, Katja Schindler, et al.Cancer Discovery|March 3, 2018
In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.European Journal of Cancer (Oxford, England : 1990)|April 6, 2021
Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete responseFlorentia Dimitriou, Anne Zaremba, Clara Allayous, et al.Cancer Research|October 14, 2021
Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma ProgressionAnnalisa Saltari, Andreas Dzung, Marika Quadri, et al.Cancer Cell|July 17, 2018
EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma FormationDaniel Zingg, Julien Debbache, Rodrigo Peña-Hernández, et al.Nature Cancer|August 29, 2024
A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanomaFlorentia Dimitriou, Phil F Cheng, Annalisa Saltari, et al.Cancer Research|September 20, 2023
Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced MelanomaLorenza P Ferretti, Flurina Böhi, Deena M Leslie Pedrioli, et al.Nature Communications|October 10, 2020
The ALPK1/TIFA/NF-κB axis links a bacterial carcinogen to R-loop-induced replication stressMichael Bauer, Zuzana Nascakova, Anca-Irina Mihai, et al.Cancer Immunology Research|November 15, 2018
Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against MelanomaSabrina A Hogan, Anaïs Courtier, Phil F Cheng, et al.Pageof 7